PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration.

Rat / Crush

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24459671 ↗2013Reported benefit

Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration.

RatCrushPeripheral-nerve crushSprague-Dawleyn = 18 rats for intravenous injection; 6 sham (vehicle) controlsIntravenous, via the femoral veinDirectly after lesion induction

Model: Sciatic nerve lesion at the level of the piriformis tendon (described as complete section by standardised nerve crush), with preoperative splenectomy

Labelled mesenchymal stromal cells were found within the regenerated sciatic nerve at 21 days. The cell-treated group showed a better sciatic functional index than fibroblast and vehicle controls at 7, 14 and 21 days, with the improvement appearing early.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.